课题基金 / 基金详情

Role of dS6 phosphorylation in dTORC1/dS6K mediated longevity in Drosophila

Role of dS6 phosphorylation in dTORC1/dS6K mediated longevity in Drosophila
dS6 磷酸化在 dTORC1/dS6K 介导的果蝇寿命中的作用
批准号:
8249374
负责人:
GEORGE THOMAS
金额:
$21.59万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2013-03-31
关键词:
AccountingAdipose tissueAffectAgingAmericanAnimal ModelAnimalsAreaBindingBinding ProteinsBiogenesisBiological ModelsCardiovascular DiseasesCardiovascular systemCessation of lifeChronicComplexCyclic AMP-Dependent Protein KinasesDataDiabetes MellitusDietDiseaseDrosophila genusEatingEpidemicEukaryotaEventEvolutionExplosionFamilyFoodGene ExpressionGeneticGenetic TranslationGoalsGrowth FactorHealthHealth Care CostsHumanHuman GeneticsInsulinInsulin ResistanceInsulin-Like Growth Factor IInterventionInvertebratesInvestigationKnock-in MouseLaboratoriesLeadLinkLongevityMalignant NeoplasmsMediatingMediator of activation proteinMessenger RNAMetabolismMetforminModelingMolecularMolecular ProfilingMusNerve DegenerationNeurodegenerative DisordersNutrientNutritionalObesityOrganismPathologyPathway interactionsPeptide Initiation FactorsPharmaceutical PreparationsPharmacotherapyPhosphorylationPhosphotransferasesPlayPolyribosomesProbabilityProcessProductionProlineProtein BiosynthesisProtein KinaseProteinsQuality of lifeRegulationResearchResistanceRibosomal Protein S6Ribosomal Protein S6 KinaseRibosomal ProteinsRibosomesRoleSignal PathwaySignal TransductionSirolimusSiteTestingTherapeuticTimeTranslatingTranslationsUnited StatesUntranslated RegionsWorkYeastsadenylate kinaseage relatedagedarmcell growthcostdietary restrictiondisorder controlflygenetic regulatory proteinhuman FRAP1 proteininnovationinsulin sensitivityloss of functionmTOR proteinmanmutantnovelnovel strategiespublic health relevanceresearch studyresponsesuccesstraittreatment strategy

项目摘要

项目成果

GEORGE THOMAS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Obesity is a worldwide epidemic that accounts for more than 300,000 deaths per year in the United States alone. Moreover, it is the major reason behind the explosion in health care costs and the disquieting observation that, for the first time in decades, human life span is decreasing for North Americans. A direct consequence of obesity is the enhanced probability of a number of age-related pathologies including diabetes, cardiovascular disease, neurodegenerative disorders, and cancer. The epidemic has been fueled by the availability, abundance, and relatively low cost of food. The critical barrier in controlling the disease has been the inability to overcome dominant human genetic traits that promote the acquisition of food and the storage of energy reserves in the form of adipose depots. It is hypothesized that these traits were selected for during evolution as a consequence of the chronic scarcity of food and that, over time, they have prevailed over those traits that suppress food intake. Given these limitations and the magnitude of the obesity epidemic, it is critical to develop novel intervention strategies, such as targeted drug therapies. The success of such strategies will depend on a basic understanding of the molecular mechanisms that drive these responses. In contrast, to nutritional overload, dietary restriction is a robust environmental manipulation that increases "healthspan", as it not only prolongs life span but also delays the onset of age-related diseases. Although under intense investigation, the underlying molecular mechanisms that lead to obesity-induced pathologies associated with age-related diseases versus those of dietary restriction-induced increases in healthspan have remained difficult to resolve. Nonetheless, one signaling pathway that has emerged as a major player in both responses is that mediated by mTORC1. Under conditions of nutritional overload, this pathway is fully activated and known to contribute to obesity and insulin resistance. In contrast, under conditions of dietary restriction this signaling pathway is suppressed, which has been demonstrated to contribute to increased healthspan. Importantly, conservation of signaling pathways in simpler eukaryotes and the rapidity with which healthspan studies can be carried out make research in model organisms such as Drosophila invaluable in elucidating healthspan-related diseases in humans. Moreover, studies in different organisms have shown that the nutrient arm of the mTORC1 signaling pathway is highly conserved from yeast to man and is a central mediator of the effect of dietary restriction. S6K1 is a well established downstream target of mTORC1 whose deficiency in the mouse has been shown to increase insulin sensitivity, increase resistance to diet-induced obesity, and increase life span, while sparing animals from much age-related pathology. Several downstream substrates of S6K1 have been identified; however, those mediating healthspan are unknown. We propose that phosphorylation of dS6, the first-identified downstream substrate of S6K1, is an essential player in dietary restriction-mediated healthspan extension. We provide preliminary data to support this novel hypothesis. PUBLIC HEALTH RELEVANCE: Obesity, which has recently become a worldwide epidemic, is well recognized for its deleterious effects on health whereas dietary restriction increases healthspan, as it delays the onset of age- related diseases. The mTORC1/S6K1 signaling pathway has emerged as a major player in both states: under conditions of nutritional overload, this pathway contributes to obesity and insulin resistance while under conditions of dietary restriction it is suppressed and increases healthspan. The proposed project will use Drosophila model and analyze a downstream effector of this signaling pathway, the phosphorylation of S6, to reveal the mechanisms by which it affects dietary restriction mediated healthspan extension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Function of rpL5 and rpL11 in induction of p53
  • 批准号:
    8236578
  • 项目类别:
  • 资助金额:
    $32.58万
  • 财政年份:
    2012
  • 负责人:
    GEORGE THOMAS
  • 依托单位:
The Function of rpL5 and rpL11 in induction of p53
  • 批准号:
    8434834
  • 项目类别:
  • 资助金额:
    $30.62万
  • 财政年份:
    2012
  • 负责人:
    GEORGE THOMAS
  • 依托单位:
The Function of rpL5 and rpL11 in induction of p53
  • 批准号:
    8819106
  • 项目类别:
  • 资助金额:
    $16.05万
  • 财政年份:
    2012
  • 负责人:
    GEORGE THOMAS
  • 依托单位:
The Function of rpL5 and rpL11 in induction of p53
  • 批准号:
    8616731
  • 项目类别:
  • 资助金额:
    $31.6万
  • 财政年份:
    2012
  • 负责人:
    GEORGE THOMAS
  • 依托单位:
海外基金